# Task B31: Bulk Intermediate Scaleup for Antibiotic-Resistant Drug Design

> **NIH NIH N01** · EUROFINS PANLABS, INC. · 2024 · $67,783

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 11193623
- **Project number:** 272201800007I-0-759302400001-1
- **Recipient organization:** EUROFINS PANLABS, INC.
- **Principal Investigator:** JACOB BODE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $67,783
- **Award type:** —
- **Project period:** 2024-09-13 → 2025-03-12

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11193623

## Citation

> US National Institutes of Health, RePORTER application 11193623, Task B31: Bulk Intermediate Scaleup for Antibiotic-Resistant Drug Design (272201800007I-0-759302400001-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11193623. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*